156 Nation Join for COVID-19 Vaccine Plan Apart from China and US

In the conference led by the World Health Organization (WHO) stated that some 156 nations have joined a global scheme for the fair distribution of the future COVID-19 Vaccine Plan but the superpower China and US did not sign up.

The US President Donald Trump said that it has already secured future supplies through bilateral deals with other countries which promoted the selfish behaviour to the detriment of poor countries. China the major epicentre of the coronavirus was also missing in the list of 64 rich nations who joined the COVAX plan with the focus to deliver 2 billion vaccines dosed around the world by the end of 2021 with high focus on healthcare workers and the vulnerable

WHO and GAVI vaccine alliance that planned the scheme and published the list of signatories after a deadline for binding commitments expired also said that the scheme would account for about two-thirds of the world population.

Coronavirus has infected about 31 million people globally and killed nearly 1 million also large numbers of players are conducting various vaccines testing across the globe. WHO Director-General Tedros Adhanom Ghebreyesus also stated that COVAX will give the world the largest and most diverse portfolio of vaccine candidates

As the wealthier country quit the COVAX plan it has highlighted the challenge of distributing vaccines equally around the globe. The vaccine alliance said it expected another 38 wealthy countries to join the initiative in coming days. The alliance has also received commitments for US$1.4 billion towards vaccine research and development and US$ 700-800 million are urgently needed.

The alliance has not disclosed the names of the countries that are providing funding also the name of countries that are not planning to take a supply of the vaccine from the scheme. France and Germany have said they will only source potential shots via the European joint procurement scheme.

For more latest news Click Here

Follow Us
Twitter: @TimesTechPharm1

Leave a Reply

Your email address will not be published. Required fields are marked *